User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

580

Interactions with Platform & by Email *

INTERACTIONS

116

Unique # Participated *

PARTICIPANTS

23

Responses Validated *

VALIDATIONS

9

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Current & Future Analysis.....II-1
Market Overview.....II-1
2$200
   A Brief Historic Account on Bioterrorism.....II-31$100
   Why Biological Agents?.....II-4
An Ideal Biological Weapon Candidate.....II-4
Bioterrorism is Easy: The Myth!.....II-4
Biological Agents/Diseases with Potential for Biological Warfare.....II-4
1$100
   Properties of Biological Agents with Potential for Use as Weapons of Mass
  Destruction.....II-5
1$100
   Anthrax.....II-6
The Anthrax History.....II-6
1$100
   Types of Anthrax.....II-7
Inhalational Anthrax.....II-7
Cutaneous Anthrax.....II-7
Gastrointestinal Anthrax.....II-7
The Anthrax Symptoms, Treatment, and Vaccination.....II-7
1$100
   Smallpox.....II-8
The Smallpox History.....II-8
1$100
   Plague.....II-9
The Plague History.....II-9
Types of Plague.....II-9
Bubonic Plague.....II-9
1$100
   Pneumonic Plague.....II-10
Botulism.....II-10
1$100
   Tularemia.....II-111$100
   The Tularemia History.....II-12
Viral Hemorrhagic Fevers.....II-12
Ebola Hemorrhagic Fever.....II-12
1$100
   Marburg Hemorrhagic Fever.....II-13
Lassa Hemorrhagic Fever.....II-13
1$100
   Q Fever.....II-141$100
   Brucellosis.....II-151$100
   Ricin.....II-16
Others.....II-16
1$100
   Aerosol Dissemination.....II-17
Water Contamination.....II-17
Food Contamination.....II-17
Insect Vectors.....II-17
1$100
   Other.....II-18
1$100
   Detection Equipment.....II-19
Point Detection Systems.....II-19
Standoff Detection Systems.....II-19
Passive Standoff Detection Systems.....II-19
Defense Products.....II-19
Vaccines.....II-19
1$100
   Personal Protective Equipment.....II-20
1$100
   Sanofi Pasteur Acquires Acambis.....II-21
PharmAthene Acquires Avecia Biodefense Vaccines Business.....II-21
ICx Technologies Completes S3I Acquisition.....II-21
1$100
   Johnson & Johnson to Acquire Omrix.....II-22
Emergent BioSolutions Enters into Joint Venture with Ninebio Sdn Bhd.....II-22
Alert B&C, Frontline Robotics, and Dragon Securite Sign MoU.....II-22
1$100
   Universal Detection and Kadinuo Sign Agreement.....II-23
PharmAthene Signs Marketing Pact with Medison for Israeli Market.....II-23
PharmAthene Forms Alliance with Panacea Biotec.....II-23
1$100
   Innovative Biosensors and Universal Detection Plan Collaboration.....II-24
Acambis Wins Government Contract for ACAM2000™ Smallpox Vaccine.....II-24
Crucell, Integrated BioTherapeutics Win NIAID Funding for Vaccine Development.....II-24
1$100
   Universal Detection Secures Repeat Order for Biodetection Kits.....II-25
Universal Detection Secures Repeat Order for Biodetection Training Equipment.....II-25
Universal Detection Secures and Completes Contract.....II-25
1$100
   Hawaii Emergency Medical Services Orders Simulation and Bio-Detection Kits.....II-26
IR BioSciences Raises Financing for Drug Development.....II-26
AVI BioPharma Files IND for Marburg.....II-26
ICx Technologies Completes GHC Technologies Acquisition.....II-26
1$100
   NanoSensors to Acquire DKL International.....II-27
Allen-Vanguard to Acquire Hazard Management Solutions.....II-27
PharmAthene Announces Reverse Merger to Acquire Healthcare Acquisition.....II-27
1$100
   CytoGenix Enters into CRADA with USAMRIID.....II-28
Advanced Life Sciences Announces Collaboration with NIAID.....II-28
U.S. BioDefense to Receive Exclusive License from Shine Holdings.....II-28
1$100
   Emergent BioSolutions Signs Agreement to License VaxImmune.....II-29
Universal Detection Signs Distribution Agreement with ADVNT.....II-29
Universal Detection Secures Gulf Security Order for Detection Kits.....II-29
Dycor Technologies Wins Rheinmetall Landsystems Contract.....II-29
1$100
   AVI BioPharma Secures Bioterrorism Response Therapies Contracts.....II-30
Emergent BioSolutions Wins HHS Anthrax Biodefense Contract.....II-30
Nanotherapeutics Wins Anti-Bioterrorism Drug Contract from NIAID/ BARDA.....II-30
1$100
   SRI International Secures Contract for Anti-Biological Threat Drugs from DTRA.....II-31
Universal Detection Completes Foot Locker Order for Bioterrorism Detection
  Kits.....II-31
PharmAthene Wins HHS Biodefense Contract.....II-31
1$100
   Ibis Biosciences Receives Four New Contracts from Government.....II-32
Universal Detection Receives Guaranteed Order from SSI.....II-32
Ichor Receives Navy Contract for Vaccine Development.....II-32
1$100
   PharmAthene Receives Contract to Develop Anthrax Anti-Toxin.....II-33
General Dynamics Canada Secures Contract from Canadian Forces.....II-33
1$100
   Universal Detection Commences R&D for Portable Anthrax Detector.....II-34
BioFactura Completes Initial Clinical Testing.....II-34
1$100
   Smiths Detection Introduces SmartBio™ Biological Agents Detector.....II-35
Safe Life Launches Triosyn Disposable Respirators.....II-35
ICx Unveils Integrated System for CBR Threat Detection, SafeAir™.....II-35
1$100
   Innovative Biosensors Unveils BioFlash Biological Detector.....II-36
Lawrence Laboratory Develops Biological, Chemical Agent Detection Machine.....II-36
1$100
   Acambis Plc (UK).....II-37
AVI BioPharma, Inc. (USA).....II-37
Blücher Gmbh (Germany).....II-37
Evogen, Inc. (USA).....II-37
1$100
   Human Genome Sciences Inc. (USA).....II-38
ICX Technologies, Inc. (USA).....II-38
ILC Dover LP (USA).....II-38
1$100
   Medarex, Inc. (USA).....II-39
Northrop Grumman Corporation (USA).....II-39
PharmAthene, Inc. (USA).....II-39
1$100
   Scott Health & Safety (USA).....II-40
Smiths Detection (USA).....II-40
The Baker Company (USA).....II-40
1$100
   Universal Detection Technology (USA).....II-41
1$100
   Table 1: World Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment by Geographic Region – US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-421$300
   Table 2: World Historic Review for Bioterrorism Detection Equipment by Geographic Region – US, Europe, Asia (Including Japan), and Middle East Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2001 through 2015 (includes corresponding Graph/Chart).....II-43

Table 3: World 10-Year Perspective for Bioterrorism Detection Equipment Market by Geographic Region – Percentage Share Breakdown of Dollar Revenue for US, Europe, Asia (Including Japan), and Middle East Markets for Years 2006, 2009, and 2015 (includes corresponding Graph/Chart).....II-43
1$300
   A. Market Analysis.....III-1
A Case of Undue Importance.....III-1
1$75
   Market Drivers.....III-2
Market Dampers.....III-2
Investment Bottlenecks.....III-2
Legislative Bottlenecks.....III-2
1$75
   Government Biodefense Funding.....III-3
The Federal Biological Weapons Prevention and Defense Funding.....III-3
1$75
   Table 4: The US Federal Government Spending on Bioweapons Prevention and Defense – Allocation of Funds in US$ Million by Department/Agency from FY2001 to FY2007 (includes corresponding Graph/Chart).....III-41$150
   Table 5: The US Federal Government Spending on Bioweapons Prevention and Defense – Percentage Share Breakdown of Funds Allocation by Department/Agency for FY2001 and FY2007 (includes corresponding Graph/Chart).....III-51$150
   Table 6: The US Federal Funding for the Department of Health and Human Services by its Constituent Agencies and Offices in US$ Million from FY2001-FY2007 (Including Requested Funding for the Year 2007) (includes corresponding Graph/Chart).....III-6
The RDT&E Biodefense Funding.....III-6
1$150
   Table 7: Biodefense Funding for Research, Development, Testing and Evaluation (RTD&E) by Agency/Department in US$ Million from FY2001 to FY2007.....III-71$150
   Biodefense Prevention Funding.....III-8
Table 8: Federal Biodefense Prevention Funding in US$ Million from FY2001 to FY2007 (includes corresponding Graph/Chart).....III-8
Recent Awards for Biodefense Preparedness.....III-8
1$150
   Government Biodefense Initiatives.....III-9
Project BioShield.....III-9
1$75
   Pandemic and All-Hazards Preparedness Act.....III-10
Public Health Security and Bioterrorism Preparedness and Response Act.....III-10
Government Departments / Agencies.....III-10
The Department of Health and Human Services.....III-10
1$75
   The National Institutes of Health.....III-11
The Centers for Disease Control and Prevention.....III-11
The CDC Classification.....III-11
2$150
   The CDC Regulated Shipment Agents.....III-131$75
   The Department of Defense.....III-141$75
   B. Market Analytics.....III-15
Table 9: US Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-15

Table 10: US Historic Review for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-15
1$150
   Table 11: US Recent Past, Current & Future Analysis for Bioterrorism Vaccines Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-16

Table 12: US Historic Review for Bioterrorism Vaccines Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-16
1$150
   Market Analysis.....III-17
Table 13: European Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-17
1$150
   Table 14: European Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-18
1$150
   A. Market Analysis.....III-19
ASEAN and Canada Forge Ties to Combat Bioterrorism.....III-19
China Plans Counter-bioterrorism Security System.....III-19
1$75
   B. Market Analytics.....III-20
Table 15: Asian Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-20

Table 16: Asian Historic Review for Bioterrorism Detection Equipment Market - Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-20
1$150
   Market Analysis.....III-21
Table 17: The Middle East Recent Past, Current & Future Analysis for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-21
1$150
   Table 18: The Middle East Historic Review for Bioterrorism Detection Equipment Market – Annual Revenue in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-221$150
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com